CytRx (CYTR) to Present Global Phase 2b Clinical Data for Aldoxorubicin at Annual Connective Tissue Oncology Society Meeting
Oncology-focused biopharmaceutical research and development company CytRx Corporation announced it will present additional preliminary data from its Phase 2b clinical…